3.1.3.15	3-[(1-(R))-1-(2,6-dichloro-4-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine	NSC756645	231321	
3.1.3.15	4-chloro-1-N,3-N-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]benzene-1,3-dicarboxamide	NSC67436	231467	
3.1.3.15	5,11-dimethyl-2-(2-piperidin-1-ylethyl)-6H-pyrido[4,3-b]carbazol-2-ium-9-ol	NSC311153, best tested inhibitor	231511	
3.1.3.15	5,5'-dithiobis(2-nitrobenzoic acid)	inhibits more rapidly at pH 7 than at pH 8.5	221	
3.1.3.15	8-hydroxyquinoline	-	321	
3.1.3.15	arsenate	-	255	
3.1.3.15	Be2+	-	3450	
3.1.3.15	Ca2+	-	15	
3.1.3.15	Ca2+	0.1 mM, no activity	15	
3.1.3.15	EDTA	0.1 mM, no activity	21	
3.1.3.15	EDTA	10 mM, complete loss of activity; 10 mM, complete loss of activity	21	
3.1.3.15	ethylenimine	-	44121	
3.1.3.15	histidine	-	1063	
3.1.3.15	histidinol	-	12794	
3.1.3.15	iodoacetamide	-	67	
3.1.3.15	iodoacetate	-	93	
3.1.3.15	Li+	slight inhibition	152	
3.1.3.15	Mg2+	-	6	
3.1.3.15	additional information	no inhibitory effect is observed by L-histidine at up to 60 mM L-histidine, by phosphate at up to 0.25 mM, or by L-histidinol at 20 mM; no inhibitory effect of L-histidine is observed with concentrations up to 60 mM L-histidine	2	
3.1.3.15	additional information	identification of several small-molecule inhibitors of the enzyme by target-based screening against HolPase, high-throughput compound library screening	2	
3.1.3.15	N-ethylmaleimide	-	49	
3.1.3.15	Ni2+	-	38	
3.1.3.15	p-chloromercuribenzoate	noncompetitive	43	
3.1.3.15	p-chloromercuribenzoate	competitive	43	
3.1.3.15	phosphate	40% inhibition at 0.375 mM	16	
3.1.3.15	vinorelbine	NSC608210	127602	
3.1.3.15	[(1S,4aR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine benzoic acid	NSC65238	232170